Myocardial infarction or chronic cardiomyopathies can cause irreversible damage to the cardiac tissue. Recent evidence for multipotent cardiovascular stem cells has raised expectations that these cells may be engaged to heal the injured myocardium. However, the biological properties of cardiovascular stem cells are poorly understood, we know little about how disease limits the regenerative potential of stem cells and, we lack pharmaceuticals to guide stem cells toward forming new cardiac tissue. To address these issues, the Vanderbilt University Hub proposes three interacting projects (P1-P3), a Hub Core and a Consortium-wide Bioinformatics Core. PI will focus on the role of adult progenitor cells in normal cardiac homeostasis and after ischemic injury. P2 will explore the regenerative potential of endocardial progenitor cells. Whereas P3 will investigate how the disease environment affects the fate of progenitor cells in the heart. We have designed a pilot study to screen small molecular libraries for compounds that Induce endocardial and myocardial differentiation. Positive hits will be evaluated for effects on cardiac stem cells and myocardial repair. The Hub structure also incorporates a Core for standardized mouse models of myocardial injury and assessment of cardiac histology and function. Finally, we propose a Bioinformatics Core to organize Consortium data into a Stem Cell database to accelerate discovery, strength the connections between Consortium partners and facilitate the dissemination of information to the scientific community and the public. The Vanderbilt Hub will create a dynamic and interactive network of investigators to advance our knowledge about the biology of cardiovascular progenitor cells and their role in cardiac tissue repair. The proposed experiments will lead to novel molecular and cellular tools for the therapy of cardiovascular diseases.

Agency
National Institute of Health (NIH)
Institute
National Heart, Lung, and Blood Institute (NHLBI)
Type
Research Project--Cooperative Agreements (U01)
Project #
5U01HL100398-05
Application #
8468195
Study Section
Special Emphasis Panel (ZHL1-CSR-J (S1))
Program Officer
Buxton, Denis B
Project Start
2009-09-30
Project End
2016-04-30
Budget Start
2013-05-01
Budget End
2014-04-30
Support Year
5
Fiscal Year
2013
Total Cost
$1,102,702
Indirect Cost
$395,842
Name
Vanderbilt University Medical Center
Department
Internal Medicine/Medicine
Type
Schools of Medicine
DUNS #
004413456
City
Nashville
State
TN
Country
United States
Zip Code
37212
Fioret, Bryan A; Heimfeld, Jeremy D; Paik, David T et al. (2014) Endothelial cells contribute to generation of adult ventricular myocytes during cardiac homeostasis. Cell Rep 8:229-41
Galindo, Cristi L; Kasasbeh, Ehab; Murphy, Abigail et al. (2014) Anti-remodeling and anti-fibrotic effects of the neuregulin-1? glial growth factor 2 in a large animal model of heart failure. J Am Heart Assoc 3:e000773
Plank, Jennifer L; Suflita, Michael T; Galindo, Cristi L et al. (2014) Transcriptional targets of Foxd3 in murine ES cells. Stem Cell Res 12:233-40
Galindo, Cristi L; Ryzhov, Sergey; Sawyer, Douglas B (2014) Neuregulin as a heart failure therapy and mediator of reverse remodeling. Curr Heart Fail Rep 11:40-9
Hao, Jijun; Galindo, Cristi L; Tran, Truc-Linh et al. (2014) Neuregulin-1? induces embryonic stem cell cardiomyogenesis via ErbB3/ErbB2 receptors. Biochem J 458:335-41
Tanwar, Vineeta; Bylund, Jeffery B; Hu, Jianyong et al. (2014) Gremlin 2 promotes differentiation of embryonic stem cells to atrial fate by activation of the JNK signaling pathway. Stem Cells 32:1774-88
Muller, Iris I; Melville, David B; Tanwar, Vineeta et al. (2013) Functional modeling in zebrafish demonstrates that the atrial-fibrillation-associated gene GREM2 regulates cardiac laterality, cardiomyocyte differentiation and atrial rhythm. Dis Model Mech 6:332-41
Hill, Michael F; Patel, Amish V; Murphy, Abigail et al. (2013) Intravenous glial growth factor 2 (GGF2) isoform of neuregulin-1? improves left ventricular function, gene and protein expression in rats after myocardial infarction. PLoS One 8:e55741
Hao, Jijun; Ao, Ada; Zhou, Li et al. (2013) Selective small molecule targeting *-catenin function discovered by in vivo chemical genetic screen. Cell Rep 4:898-904
Rai, Meena; Walthall, Joel M; Hu, Jianyong et al. (2012) Continuous antagonism by Dkk1 counter activates canonical Wnt signaling and promotes cardiomyocyte differentiation of embryonic stem cells. Stem Cells Dev 21:54-66

Showing the most recent 10 out of 23 publications